High Outlier
Strength
20 mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287004515
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
10/1/2025
Active Ingredients
TADALAFILApproval Type
New Drug (NDA)
FDA Application
NDA214522On Market Since
8/30/2022
Pharmacological Classes
Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
REVATIO 20 MG TABLET
Brand
00069419068•Pfizer Inc.
$46.6786
per EA
VIAGRA 25 MG TABLET
Brand
00069420030•Pfizer Inc.
$74.9876
per EA
VIAGRA 100 MG TABLET
Brand
00069422030•Pfizer Inc.
$83.6319
per EA
VIAGRA 100 MG TABLET
Brand
00069422066•Pfizer Inc.
$83.6319
per EA
VIAGRA 100 MG TABLET
Brand
58151042893•Viatris Specialty LLC
$83.6319
per EA
VIAGRA 50 MG TABLET
Brand
00069421030•Pfizer Inc.
$84.5695
per EA
VIAGRA 50 MG TABLET
Brand
00069421066•Pfizer Inc.
$84.5695
per EA
VIAGRA 50 MG TABLET
Brand
58151042701•Viatris Specialty LLC
$84.5695
per EA